Four members of the Sol Goldman Pancreatic Cancer Research Center at Johns Hopkins were identified as "highly influential" biomedical researchers (1996-2011) in a study of published scientific articles. The study tracked the number of times an author's work is cited by other scientists to develop a list of the top 400 living most influential biomedical researchers in the world. Drs. Cameron, Hruban, Kinzler and Vogelstein from the Goldman Center at Johns Hopkins were the only pancreatic cancer researchers on the list. This honor highlights the extraordinary impact of the pancreatic cancer research at Johns Hopkins. Congratulations to Drs. Cameron, Hruban, Kinzler and Vogelstein!
A list of highly influential biomedical researchers, 1996-2011.
Boyack KW, Klavans R, Sorensen AA, Ioannidis JP.
Eur J Clin Invest. 2013 Dec;43(12):1339-65.
It can be difficult to find a doctor or medical center with the expertise in a particular disease. Dr. John Sotos and colleagues have developed a unique Web-based tool, called ExpertScape, to help patients and their families identify disease-specific experts. ExpertScape's unique algorithm is based on the idea that true experts are "investigating the leading edge of knowledge and are writing about it." ExpertScape therefore bases its rankings on scientific publications. ExpertScape recently analyzed over 2,900 articles on pancreatic cancer and the Johns Hopkins University came out ranked as the leading expert center on pancreatic cancer. In addition, Dr. Ralph Hruban, the head of the Sol Goldman Pancreatic Cancer Research Center at Johns Hopkins was identified as the world's leading expert on pancreatic cancer. While no system is perfect, it is gratifying to receive this special recognition.